According to SatyaNadella on X, Microsoft has trained a multimodal AI model that infers spatial proteomics directly from routine pathology slides, aiming to reduce time and cost while expanding access to cancer care. As reported by Satya Nadella’s post, the approach leverages standard histopathology images to predict protein expression maps, potentially replacing or triaging expensive spatial omics assays. According to the original X post, this could streamline oncology workflows by enabling earlier biomarker insights, faster trial screening, and broader deployment in community hospitals where spatial profiling instruments are scarce. As reported by the same source, the business impact includes lower per-sample costs, higher lab throughput, and new companion diagnostic offerings for biopharma partners.